Literature DB >> 2156937

An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA).

N Rasmussen1, C Sjölin, B Isaksson, P Bygren, J Wieslander.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of circulating anti-neutrophil cytoplasm antibodies (ANCA), which are defined by a diffuse, granular staining of the cytoplasm of alcohol-fixed human neutrophils by indirect immunofluorescence (IIF). Detection of antineutrophil cytoplasm antibodies has a high sensitivity and specificity for active Wegener's granulomatosis (WG) and reflects the effect of treatment. In the present enzyme-linked assay, immunoplates were coated with the cytoplasmic alpha fraction of neutrophils obtained from apparently healthy human donors by nitrogen bomb cavitation and subsequent Percoll gradient centrifugation. Alkaline phosphatase-labelled anti-human IgG was used as a secondary antibody. Diluted sera from 70 patients with WG and 16 patients with other diseases with anti-myeloperoxidase antibodies (anti-MPO) were examined. It is concluded that the ELISA accurately detects IIF ANCA positive patients with WG, is helpful in detecting WG patients in remission, is not influenced by the presence of anti-MPO and may help in detecting ANCA in cases with granulocyte-specific anti-nuclear antibodies since this IIF pattern obscures the IIF ANCA patterns. The ELISA with titration can be carried out in 3.5 h whereas a rapid test just to detect ANCA can be performed in 30 min.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156937     DOI: 10.1016/0022-1759(90)90350-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.

Authors:  H Chikazawa; K Nishiya; A Matsumori; K Hashimoto
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

2.  Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.

Authors:  K Nishiya; H Chikazawa; S Nishimura; N Hisakawa; K Hashimoto
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 3.  The antigenic significance and methods of detection of the anti-neutrophil cytoplasmic autoantibodies (ANCA).

Authors:  X Bosch; R A Asherson
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

4.  Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.

Authors:  S S Badakere; Vandana D Pradhan; A F Almeida; Aruna R Pawar
Journal:  J Fluoresc       Date:  2004-07       Impact factor: 2.217

5.  Increased prevalence of autoantibodies in celiac disease.

Authors:  A Lerner; M Blank; N Lahat; Y Shoenfeld
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

6.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.

Authors:  E Peen; S Almer; G Bodemar; B O Rydén; C Sjölin; K Tejle; T Skogh
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

7.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese.

Authors:  J Y Sung; F K Chan; J Lawton; J C Leung; C T Liew; N W Leung; R Hsu; K N Lai
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

9.  Urinary thrombin: a novel marker of glomerular inflammation for the diagnosis of crescentic glomerulonephritis (prospective observational study).

Authors:  Yasunori Kitamoto; Kenji Arizono; Hiroyoshi Fukui; Kimio Tomita; Hiroshi Kitamura; Yoshio Taguma; Takahisa Imamura
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

10.  BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.

Authors:  Ulrika Lindberg; Malin Carlsson; Claes-Göran Löfdahl; Mårten Segelmark
Journal:  Clin Dev Immunol       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.